Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleiotropic effects of statins.

J A Farmer1

  • 1Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. Jfarmer@bcm.tmc.edu

Current Atherosclerosis Reports
|December 21, 2000
PubMed
Summary

Statins significantly reduce cardiovascular and total mortality in patients with dyslipidemia. This review explores their pleiotropic effects beyond lipid lowering, which may also contribute to reducing ischemic event risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of Raman spectroscopy to identify and characterize transitional cell carcinoma in vitro.

BJU international·2004
Same author

Managing heart failure with immunomodulatory agents.

Cardiology clinics·2001
Same author

Learning from the cerivastatin experience.

Lancet (London, England)·2001
Same author

Pleiotropic effects of statins: do they matter?

Current opinion in lipidology·2001
Same author

Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha.

Circulation·2001
Same author

Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys.

Pharmaceutical research·2001

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Dyslipidemia is a major risk factor for ischemic events.
  • Statin therapy has revolutionized cardiovascular risk management.
  • Clinical trials confirm statins reduce cardiovascular and total mortality.

Purpose of the Study:

  • To review the pleiotropic (non-lipid-lowering) effects of statin therapy.
  • To explore the role of these pleiotropic effects in reducing ischemic event risk.

Main Methods:

  • Review of large-scale clinical trials and scientific literature.
  • Analysis of proposed mechanisms of statin action.

Main Results:

  • Statins demonstrably reduce cardiovascular and total mortality.
  • Controversy exists regarding whether benefits stem from lipid lowering or pleiotropic effects.
  • Potential pleiotropic effects include improved endothelial function, reduced inflammation, and enhanced plaque stability.

Conclusions:

  • Statin therapy offers significant mortality benefits in dyslipidemia.
  • Pleiotropic effects of statins may play a crucial role in cardiovascular risk reduction.
  • Further research is warranted to elucidate the precise contribution of pleiotropic effects.

Related Experiment Videos